Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Medical ethics have yet to be passed
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Patients in the intensive care unit (ICU) are often at risk of gastrointestinal dysfunction and malnutrition. Gastrointestinal dysfunction was associated with poor clinical outcomes, including prolonged mechanical ventilation, prolonged ICU stay and increased 90-day mortality.
There have been some clinical studies investigating the effects of traditional Chinese acupoint massage, acupuncture, or moxibustion of 7 acupoints (Zhongwan Point (CV12), Tianshu Point (ST25), Qihai Point (CV6), Zusanli point (ST36), Shangjuxu Point (ST37), Neiguan Point (PC6) and Hegu Point (LI4)) on gastrointestinal function recovery. Gastrointestinal dysfunction could be improved by stimulating single acupoint or combining multiple acupoints, and the effects of combined stimulation of multiple acupoints was better for the improvement of gastrointestinal dysfunction.
This project aims to study the effects of traditional Chinese acupoint massage, acupuncture, or moxibustion of 7 acupoints (Zhongwan Point (CV12), Tianshu Point (ST25), Qihai Point (CV6), Zusanli point (ST36), Shangjuxu Point (ST37), Neiguan Point (PC6) and Hegu Point (LI4)) on the 28-day survival, and the gastrointestinal function recovery in critically ill patients with with gastrointestinal dysfunction caused by medical diseases and critically ill patients with high risk of malnutrition in ICU, and to observe their effects on the recovery of gastrointestinal barrier function by measuring the serum intestinal fatty acid binding protein (iFABP), citrulline, diamine oxidase (DAO) and D-lactic acid. Studies have shown that serum iFABP, citrulline, DAO and D-lactic acid could reflect the intestinal barrier function of the patients.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| massage group | patients with gastrointestinal function injury caused by medical diseases or with high risk of malnutrition who got massage | ||
| non-massage group | patients with gastrointestinal function injury caused by medical diseases or with high risk of malnutrition who got no massage |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| 28-day survival rate (%) | Survival at 28 days after hospitalization | Up to 4 weeks |
| Ultrasound assessment of gastrointestinal function: ACF (times/min) | Antral contraction frequency (ACF): In semi-recumbent position at 45°, infuse the stomach with 300ml of warm water. Within 6 minutes after infusion, divide the number of antral contractions by 3. | 0, 24, 48, 72, 96 and 120 hours after study inclusion |
| Ultrasound assessment of gastrointestinal function: ACA (%) | Antral contraction amplitude (ACA): Measure the area during 3 maximum relaxations (S relaxation) and minimum contractions (S contraction), calculate the change in antral area (ΔS = S relaxation - S contraction), and take the average of 3 measurements. Antral contraction amplitude: ΔS/S relaxation. | 0, 24, 48, 72, 96 and 120 hours after study inclusion |
| Ultrasound assessment of gastrointestinal function: MI | Motility index (MI): ACF × ACA. | 0, 24, 48, 72, 96 and 120 hours after study inclusion |
| Ultrasound assessment of gastrointestinal function: GET (min) | Gastric emptying time (GET): In semi-recumbent position at 45°, infuse the stomach with 300ml of warm water. Use the maximum antral relaxation as the standard and measure the area every 5 minutes until the liquid in the antrum is emptied. The time it takes for the gastric antrum to empty is GET. | 0, 24, 48, 72, 96 and 120 hours after study inclusion |
| Ultrasound assessment of gastrointestinal function: intestinal wall thickness (mm) | Intestinal wall thickness of Jejunum/Ileum/Colon: Refers to the distance between the serosal and mucosal surfaces of the intestinal wall. The normal thickness of the small intestine is 2-3mm, and >3mm may indicate thickening of the intestinal wall; the thickness of the colon wall is approximately 3-4mm, and >5mm may suggest thickening of the intestinal wall. Attention should be paid to the colon pocket and the plica structure on the colon wall. |
| Measure | Description | Time Frame |
|---|---|---|
| Daily amount of enteral nutrition feeding (ml) | Daily amount of enteral nutrition feeding | Within 5 days after study inclusion |
| Daily gastric residual volume (ml) | Daily gastric residual volume |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Adult critically ill patients at high risk of malnutrition due to gastrointestinal functional impairment caused by medical diseases in the ICU, and AGI grade I-II or NRS 2002 score ≥3.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Wuhan | Hubei | 430022 | China |
Not provided
Not provided
Not provided
Not provided
| 0, 24, 48, 72, 96 and 120 hours after study inclusion |
| Ultrasound assessment of gastrointestinal function: intestinal diameter (cm) | Intestinal diameter of Jejunum/Ileum/Colon: When not under pressure, the measurement of the width of the small intestine often refers to the distance between the mucosal surfaces of the intestinal wall. The intestinal lumen width of the small intestine (jejunum/ileum) is generally <2cm, and >3cm may indicate intestinal dilation; the internal diameter of the colon is generally <5cm. | 0, 24, 48, 72, 96 and 120 hours after study inclusion |
| Ultrasound assessment of gastrointestinal function: intestinal motility | Intestinal motility of Jejunum/Ileum/Colon (yes or no): Under normal circumstances, intestinal movement can be clearly judged at the ultrasound interface. When the intestine is filled with gas or accompanied by intestinal dilation, intestinal motility can be judged by the "creeping gas sign" of the gas or the movement of the contents. In addition, attention should be paid to the intestinal motility caused by the pressure on the intestinal tube when moving the probe. | 0, 24, 48, 72, 96 and 120 hours after study inclusion |
| Within 5 days after study inclusion |
| Serum levels of intestinal fatty acid binding protein (iFABP, ng/ml) | Serum levels of iFABP measured by ELISA. | 0, 72 and 120 hours after study inclusion |
| Serum levels of citrulline (μmol/L) | Serum levels of citrulline measured by ELISA. | 0, 72 and 120 hours after study inclusion |
| Serum levels of diamine oxidase (DAO, U/L) | Serum levels of DAO measured by ELISA. | 0, 72 and 120 hours after study inclusion |
| Serum levels of D-lactic acid (mmol/L) | Serum levels of D-lactic acid measured by ELISA. | 0, 72 and 120 hours after study inclusion |
| Superior mesenteric artery resistance index | Superior mesenteric artery resistance index evaluated by ultrasound | 0, 72 and 120 hours after study inclusion |
| Intra-abdominal pressure (IAP) (mmHg) | Intra-abdominal pressure (IAP) | 0, 24, 48, 72, 96 and 120 hours after study inclusion |
| Diarrhea | Yes (numbers) or No | 0, 24, 48, 72, 96 and 120 hours after study inclusion |
| Alimentary tract hemorrhage | Yes (numbers) or No | 0, 24, 48, 72, 96 and 120 hours after study inclusion |
| Prealbumin concentration (g/L) | Serum levels of prealbumin | 0, 72 and 120 hours after study inclusion |
| Acute physiology and chronic health evaluation (APACHE) Ⅱ score | 0-67, higher scores correspond to more severe disease and a higher risk of death | 0, 24, 48, 72, 96 and 120 hours after study inclusion |
| ICU length of stay (days) | ICU length of stay | Up to 4 weeks |
| In-hospital mortality (%) | Mortality rate during hospitalization | Up to 4 weeks |
| Peripheral venous blood CRP concentration (mg/L) | CRP level measured by blood routine examination | 0, 24, 48, 72, 96 and 120 hours after study inclusion |
| Peripheral venous blood hemoglobin concentration (g/L) | Hemoglobin level measured by blood routine examination | 0, 24, 48, 72, 96 and 120 hours after study inclusion |
| Absolute number of white blood cells in the peripheral venous blood (number/L) | Absolute number of white blood cells measured by blood routine examination | 0, 24, 48, 72, 96 and 120 hours after study inclusion |
| Absolute number of platelets in the peripheral venous blood (number/L) | Absolute number of platelets measured by blood routine examination | 0, 24, 48, 72, 96 and 120 hours after study inclusion |
| Absolute number of lymphocytes in the peripheral venous blood (number/L) | Absolute number of lymphocytes measured by blood routine examination | 0, 24, 48, 72, 96 and 120 hours after study inclusion |
| Whole blood pH | Arterial pH measured by blood gas analysis | 0, 24, 48, 72, 96 and 120 hours after study inclusion |
| Arterial PaO2 (mmHg) | Arterial PaO2 measured by blood gas analysis | 0, 24, 48, 72, 96 and 120 hours after study inclusion |
| Arterial PaCO2 (mmHg) | Arterial PaCO2 measured by blood gas analysis | 0, 24, 48, 72, 96 and 120 hours after study inclusion |
| Arterial bicarbonate (mmol/L) | Arterial bicarbonate measured by blood gas analysis | 0, 24, 48, 72, 96 and 120 hours after study inclusion |
| Arterial lactic acid (mmol/L) | Arterial lactic acid measured by blood gas analysis | 0, 24, 48, 72, 96 and 120 hours after study inclusion |
| Peripheral venous blood albumin concentration (g/L) | Albumin level measured by Blood biochemical examination | 0, 24, 48, 72, 96 and 120 hours after study inclusion |
| Peripheral venous blood total bilirubin concentration (μmol/L) | Total bilirubin level measured by Blood biochemical examination | 0, 24, 48, 72, 96 and 120 hours after study inclusion |
| Peripheral venous blood bound bilirubin concentration (μmol/L) | Bound bilirubin level measured by Blood biochemical examination | 0, 24, 48, 72, 96 and 120 hours after study inclusion |
| Peripheral venous blood creatinine concentration (μmol/L) | Creatinine level measured by Blood biochemical examination | 0, 24, 48, 72, 96 and 120 hours after study inclusion |
| Peripheral venous blood ALT concentration (U/L) | ALT level measured by Blood biochemical examination | 0, 24, 48, 72, 96 and 120 hours after study inclusion |
| Peripheral venous blood AST concentration (U/L) | AST level measured by Blood biochemical examination | 0, 24, 48, 72, 96 and 120 hours after study inclusion |